| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden;
Division of Neurology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden; and
Section of Cytokine Biology, Biomedical Primate Research Center, Rijswijk, The Netherlands
Autoantigen administration via nasal mucosal tissue can induce
systemic tolerance more effectively than oral administration in a
number of experimental autoimmune diseases, including Ab-mediated
experimental autoimmune myasthenia gravis, a murine model of myasthenia
gravis. The mechanisms underlying nasal tolerance induction are not
clear. In this study, we show that nasal administration of
acetylcholine receptor (AChR) in C57BL/6 mice, before immunizations
with AChR in adjuvant, results in delayed onset and reduced muscle
weakness compared with control mice. The delayed onset and reduced
muscle weakness were associated with decreased AChR-specific lymphocyte
proliferation and decreased levels of anti-AChR Abs of the IgG2a
and IgG2b isotypes in serum. The clinical and immunological changes in
the AChR-pretreated C57BL/6 wild-type (wt) mice were comparable with
those observed in AChR-pretreated CD8-/- mice, indicating
that CD8+ T cells were not required for the generation of
nasal tolerance. AChR-pretreated wt and CD8-/- mice
showed augmented TGF-ß and reduced IFN-
responses, whereas levels
of IL-4 were unaltered. Splenocytes from AChR-pretreated wt and
CD8-/- mice, but not from CD4-/- mice,
suppressed AChR-specific lymphocyte proliferation. This suppression
could be blocked by Abs against TGF-ß. Thus, our results demonstrate
that the suppression induced in the present model is independent of
CD8+ T cells and suggest the involvement of Ag-specific
CD4+ Th3 cells producing TGF-ß.
This article has been cited by other articles:
|
|
 |
|
  J. LINDSTROM, J. LUO, and A. KURYATOV Myasthenia Gravis and the Tops and Bottoms of AChRs: Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 29 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Aricha, T. Feferman, S. Fuchs, and M. C. Souroujon Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia Gravis J. Immunol., February 15, 2008; 180(4): 2132 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.H.M. van Puijvelde, A.D. Hauer, P. de Vos, R. van den Heuvel, M.J.C. van Herwijnen, R. van der Zee, W. van Eden, T.J.C. van Berkel, and J. Kuiper Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis Circulation, October 31, 2006; 114(18): 1968 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Cao, E. Armstrong, A. Schlachterman, L. Wang, D. K. Okita, B. Conti-Fine, K. A. High, and R. W. Herzog Immune deviation by mucosal antigen administration suppresses gene-transfer-induced inhibitor formation to factor IX Blood, July 15, 2006; 108(2): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liu, A. La Cava, X.-F. Bai, Y. Jee, M. Price, D. I. Campagnolo, P. Christadoss, T. L. Vollmer, L. Van Kaer, and F.-D. Shi Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia J. Immunol., December 15, 2005; 175(12): 7898 - 7904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-m. Chen, M. J. O'Shaughnessy, I. Gramaglia, A. Panoskaltsis-Mortari, W. J. Murphy, S. Narula, M. G. Roncarolo, and B. R. Blazar IL-10 and TGF-{beta} induce alloreactive CD4+CD25- T cells to acquire regulatory cell function Blood, June 15, 2003; 101(12): 5076 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paas-Rozner, M. Sela, and E. Mozes A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells PNAS, May 27, 2003; 100(11): 6676 - 6681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ostlie, M. Milani, W. Wang, D. Okita, and B. M. Conti-Fine Absence of IL-4 Facilitates the Development of Chronic Autoimmune Myasthenia Gravis in C57BL/6 Mice J. Immunol., January 1, 2003; 170(1): 604 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Namba, N. Kitaichi, T. Nishida, and A. W. Taylor Induction of regulatory T cells by the immunomodulating cytokines {alpha}-melanocyte-stimulating hormone and transforming growth factor-{beta}2 J. Leukoc. Biol., November 1, 2002; 72(5): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Kaya, K. M. Dohmen, Y. Wang, J. Schlichting, M. Afanasyeva, F. Leuschner, and N. R. Rose Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis J. Immunol., February 15, 2002; 168(4): 1552 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D Dick, V. Sharma, and J. Liversidge Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy Br. J. Ophthalmol., August 1, 2001; 85(8): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-R. Jiang, N. Taylor, L. Duncan, A. D Dick, and J. V Forrester Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction Br. J. Ophthalmol., June 1, 2001; 85(6): 739 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-B. Wang, F.-D. Shi, H. Li, B. J. Chambers, H. Link, and H.-G. Ljunggren Anti-CTLA-4 Antibody Treatment Triggers Determinant Spreading and Enhances Murine Myasthenia Gravis J. Immunol., May 15, 2001; 166(10): 6430 - 6436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Ostlie, P. I. Karachunski, W. Wang, C. Monfardini, M. Kronenberg, and B. M. Conti-Fine Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis J. Immunol., April 15, 2001; 166(8): 4853 - 4862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Godsel, K. Wang, B. A. Schodin, J. S. Leon, S. D. Miller, and D. M. Engman Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance Circulation, March 27, 2001; 103(12): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. REYNOLDS and C. D. PUSEY Oral Administration of Glomerular Basement Membrane Prevents the Development of Experimental Autoimmune Glomerulonephritis in the WKY Rat J. Am. Soc. Nephrol., January 1, 2001; 12(1): 61 - 70. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Faber-Elmann, V. Grabovsky, M. Dayan, M. Sela, R. Alon, and E. Mozes Cytokine profile and T cell adhesiveness to endothelial selectins: in vivo induction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand Int. Immunol., December 1, 2000; 12(12): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. E. van Tienhoven, C. P. M. Broeren, A. Noordzij, J. P. A. Wagenaar, W. van Eden, and M. H. M. Wauben Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis Int. Immunol., December 1, 2000; 12(12): 1715 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, M. Afanasyeva, S. L. Hill, Z. Kaya, and N. R. Rose Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1992 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-D. Shi, K. Takeda, S. Akira, N. Sarvetnick, and H.-G. Ljunggren IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-{gamma} by NK Cells J. Immunol., September 15, 2000; 165(6): 3099 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Poszepczynska, M. Bagot, H. Echchakir, D. Martinvalet, M. Ramez, D. Charue, L. Boumsell, and A. Bensussan Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma Blood, August 1, 2000; 96(3): 1056 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cenci, A. Mencacci, A. Bacci, F. Bistoni, V. P. Kurup, and L. Romani T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis J. Immunol., July 1, 2000; 165(1): 381 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. TAYLOR, D. G. YEE, T. NISHIDA, and K. NAMBA Neuropeptide Regulation of Immunity: The Immunosuppressive Activity of Alpha-Melanocyte-Stimulating Hormone ({alpha}-MSH) Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 239 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paas-Rozner, M. Dayan, Y. Paas, J.-P. Changeux, I. Wirguin, M. Sela, and E. Mozes Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice PNAS, February 29, 2000; 97(5): 2168 - 2173. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
